Genomics News and Research

RSS

Genomics is the study of the complete genetic material, including genes and their functions, of an organism.

A convergent coexpression approach identifies novel genes associated with autism

The current study analyzes transcriptional convergence across many autism risk genes.

14 Mar 2023

New genetic animal model may inform potential therapeutic options for Down syndrome

National Institutes of Health researchers compared a new genetic animal model of Down syndrome to the standard model and found the updated version to be more similar to the changes seen in humans.

14 Mar 2023

XBP1s plays a key role in controlling IL-15-mediated NK cell survival, study shows

A new study published in Science Immunology points to a promising therapeutic approach for future cancer treatments based on natural killer cells (NK), which are immune cells that bind to tumor cells and destroy them.

14 Mar 2023

Study suggests a new way to develop intra-tumor immunotherapies to fight head and neck cancer

Researchers at University of California San Diego School of Medicine and Moores Cancer Center at UC San Diego Health have identified a strong association between the product of a gene expressed in most cancers, including the most common type of head and neck cancer, and elevated levels of white blood cells that produce antibodies within tumors.

13 Mar 2023

Schizophrenia risk conferred by rare damaging genetic variants is conserved across ethnicities

Researchers have identified two previously unknown genes linked to schizophrenia and newly implicated a third gene as carrying risk for both schizophrenia and autism.

13 Mar 2023

Active disease process in early CTE differs substantially from late-stage disease

Millions of people, including athletes who play contact sports, members of the military and victims of domestic violence, are exposed to repetitive head impacts (RHI), which is the primary risk factor for developing chronic traumatic encephalopathy (CTE).

13 Mar 2023

Simple genetic urine test shows potential for early detection of bladder cancer

Testing for genetic mutations in urine can detect bladder cancer years before the disease shows clinical symptoms, new research has shown.

13 Mar 2023

MGI supports a national genomic sequencing project that aims to build the largest genetic database in Brazil

MGI Tech Co. Ltd. (MGI), a company committed to building core tools and technology to lead life science, in partnership with Pensabio - a Brazilian distribution company, brings to Brazil a new technology to support a large national genomic sequencing project with sequencers.

From MGI 10 Mar 2023

PacBio to commence first customer shipments of Revio long-read sequencing systems

PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023.

9 Mar 2023

Cedars-Sinai study reveals new insights into the effects of hormonal treatment for transgender men

New insights into the effects of a hormonal treatment for transgender men, discovered by Cedars-Sinai investigators, could have implications for the treatment of breast cancer.

8 Mar 2023

Most athletes with diagnosed and treated genetic heart disease experienced no cardiac events

Ninety-five percent of athletes with a diagnosed and treated genetic heart disease experienced no disease-triggered cardiac events, such as cardiogenic fainting or seizures, implantable cardio-defibrillator (ICD) shocks, sudden cardiac arrest or sudden cardiac death, during an average of seven years of follow up, according to a study being presented at the American College of Cardiology's Annual Scientific Session Together With the World Congress of Cardiology.

6 Mar 2023

Large-scale longitudinal study of neutralizing antibody responses to norovirus in children

Researchers characterized serological neutralizing antibody responses to norovirus among young children, transitioning between sequential GII.4 pandemic strains, DH 2006, NO 2009, and SY 2012.

3 Mar 2023

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

A reprogramming of which genes are active, and which are not, is visible in post-COVID sufferers. This is shown in a study from Linköping University, Sweden, on a small group of individuals.

28 Feb 2023

Rare Diseases Action Plan for England focuses on providing better care and reducing health inequalities

A new Rare Diseases Action Plan for England will be published today (Tuesday 28 February) that will ensure those living with these conditions receive better care and treatment, fairer access to testing and have continued support.

28 Feb 2023

Tecan and Oxford Nanopore build alliance to create automated, seamless and fully compatible nanopore sequencing library preparation for any-length fragments of native DNA/RNA

The Tecan Group and Oxford Nanopore Technologies plc (Oxford Nanopore) today announce their collaboration to drive easier high-throughput nanopore library preparation in an automated, hands-free fashion.

From Tecan 27 Feb 2023

New method can potentially catch COVID-19 infections quickly with near-perfect accuracy

By inspecting the body's immune response at a molecular level, a research team has developed a new way to test patients for COVID-19.

27 Feb 2023

Using AI for early diagnosis of cardiovascular disease

Researchers may be able to predict cardiovascular disease – such as arterial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study.

27 Feb 2023

NHS COVID-19 contact tracing app worked well during the pandemic, research says

A team of experts at the Pandemic Sciences Institute at the University of Oxford and Department of Statistics at the University of Warwick estimate the NHS COVID-19 app prevented around 1 million cases, 44,000 hospitalizations and 9,600 deaths during its first year.

24 Feb 2023

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

A decade-long international study into kidney cancer has shown that doctors can predict the likelihood of a patient's disease returning by looking at DNA mutations in their tumors.

24 Feb 2023

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

Studying the mutations in kidney cancer after surgery could help to better predict the risk of the disease coming back, according to the latest results of a decade-long international study.

23 Feb 2023

Genomics News and Research

Further Reading

A convergent coexpression approach identifies novel genes associated with autism

New genetic animal model may inform potential therapeutic options for Down syndrome

XBP1s plays a key role in controlling IL-15-mediated NK cell survival, study shows

Study suggests a new way to develop intra-tumor immunotherapies to fight head and neck cancer

Schizophrenia risk conferred by rare damaging genetic variants is conserved across ethnicities

Active disease process in early CTE differs substantially from late-stage disease

Simple genetic urine test shows potential for early detection of bladder cancer

MGI supports a national genomic sequencing project that aims to build the largest genetic database in Brazil

PacBio to commence first customer shipments of Revio long-read sequencing systems

Cedars-Sinai study reveals new insights into the effects of hormonal treatment for transgender men

Most athletes with diagnosed and treated genetic heart disease experienced no cardiac events

Large-scale longitudinal study of neutralizing antibody responses to norovirus in children

Study finds unique epigenetic biosignature in individuals with post-COVID syndrome

Rare Diseases Action Plan for England focuses on providing better care and reducing health inequalities

Tecan and Oxford Nanopore build alliance to create automated, seamless and fully compatible nanopore sequencing library preparation for any-length fragments of native DNA/RNA

New method can potentially catch COVID-19 infections quickly with near-perfect accuracy

Using AI for early diagnosis of cardiovascular disease

NHS COVID-19 contact tracing app worked well during the pandemic, research says

Predicting the likelihood of kidney cancer recurrence by looking at DNA mutations

DNA sequencing may help predict a patient’s risk of kidney cancer recurrence

NGS for Infectious Disease Surveillance eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo